Xenon Pharmaceuticals

XENENasdaq Canada Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$6.125 B

$63.36 -1.84%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$345.9M

Loss-making

Shares outstanding

96,840,432

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#49Belite BioBLTE$6.41B
#50ErascaERAS$6.30B
#51Xenon PharmaceuticalsXENE$6.12B
#52Ptc TherapeuticsPTCT$6.12B
#53Dianthus TherapeuticsDNTH$6.09B

Where these numbers come from

Share counts and financials for Xenon Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.